Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AR-15512 (Tryptyr) in dry eye disease
NCT04498182Phase 2Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Oct 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acoltremon in dry eye disease (DED), sponsored by Aerie Pharmaceuticals. Started Oct 2020; status: completed.
02
Drugs
acoltremon
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04498182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04498182.